4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-011949
President sold 85,000 shares at an average $33.57 ($2,853,294)
- President acquired 85,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2020-02-20 | Option exercise | +80,000 | $0.84 | $67,200 | 80,000 | D |
| RUBINSTEIN JULIE President | 2020-02-20 | Sale | −67,800 | $33.49 | $2,270,622 | 12,200 | D |
| RUBINSTEIN JULIE President | 2020-02-20 | Sale | −12,200 | $34.01 | $414,922 | 0 | D |
| RUBINSTEIN JULIE President | 2020-02-21 | Option exercise | +5,000 | $0.84 | $4,200 | 5,000 | D |
| RUBINSTEIN JULIE President | 2020-02-21 | Sale | −5,000 | $33.55 | $167,750 | 0 | D |
| Derivatives | |||||||
| RUBINSTEIN JULIE President | 2020-02-20 | Option exercise · Stock Option (Right to Buy) | −80,000 | 225,000 | D | ||
| RUBINSTEIN JULIE President | 2020-02-21 | Option exercise · Stock Option (Right to Buy) | −5,000 | 220,000 | D | ||
| Open-market sales · 85,000 sh · avg $33.57 · $2,853,294 | |||||||
Loading xslF345X03/doc4.xml…